Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Johnson

Showing results (51-60 of 218) with videos related to

Pageof 22
Sort By:
Best Practice & Research. Clinical Haematology|December 7, 2002
Molecular remission and non-Hodgkin's lymphomaAngela J Darby, Peter W M Johnson
Nature Reviews. Clinical Oncology|September 7, 2011
Chemotherapy: Advanced Hodgkin lymphoma--balancing toxicity and cureSean H Lim, Peter W M Johnson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2025
Antibody-Based Therapies for the Treatment of Hodgkin Lymphoma in Older PatientsVivek S Radhakrishnan, Peter W M Johnson
Hematology. American Society of Hematology. Education Program|December 17, 2008
Primary mediastinal B-cell lymphomaPeter W M Johnson, Andrew J Davies
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2016
HD2000 Update in Hodgkin Lymphoma-ABVD or BEACOPP?Theodoros P Vassilakopoulos, Peter W M Johnson
Journal of Clinical Microbiology|June 24, 2000
Heat-labile serotyping of two Campylobacter jejuni strains isolated from patients with Guillain-Barré syndrome and belonging to serotype O19 (Penner)R S Tsang, P Frosk, W M Johnson
Chest|June 19, 1998
Double jeopardy: lung cancer after cardiac transplantationW M Johnson, O Baldursson, T J Gross
Infection and Immunity|May 1, 1978
Heat-stable enterotoxin from Escherichia coli: factors involved in growth and toxin productionW M Johnson, H Lior, K G Johnson
Lancet (London, England)|January 1, 1983
Cytotoxic Escherichia coli O157:H7 associated with haemorrhagic colitis in CanadaW M Johnson, H Lior, G S Bezanson
The International Journal of Biochemistry & Cell Biology|October 12, 2004
Mcl-1Jorg Michels, Peter W M Johnson, Graham Packham
Pageof 22

Showing results (51-60 of 218) with videos related to

Sort By:
Pageof 22
Best Practice & Research. Clinical Haematology|December 7, 2002
Molecular remission and non-Hodgkin's lymphomaAngela J Darby, Peter W M Johnson
Nature Reviews. Clinical Oncology|September 7, 2011
Chemotherapy: Advanced Hodgkin lymphoma--balancing toxicity and cureSean H Lim, Peter W M Johnson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2025
Antibody-Based Therapies for the Treatment of Hodgkin Lymphoma in Older PatientsVivek S Radhakrishnan, Peter W M Johnson
Hematology. American Society of Hematology. Education Program|December 17, 2008
Primary mediastinal B-cell lymphomaPeter W M Johnson, Andrew J Davies
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2016
HD2000 Update in Hodgkin Lymphoma-ABVD or BEACOPP?Theodoros P Vassilakopoulos, Peter W M Johnson
Journal of Clinical Microbiology|June 24, 2000
Heat-labile serotyping of two Campylobacter jejuni strains isolated from patients with Guillain-Barré syndrome and belonging to serotype O19 (Penner)R S Tsang, P Frosk, W M Johnson
Chest|June 19, 1998
Double jeopardy: lung cancer after cardiac transplantationW M Johnson, O Baldursson, T J Gross
Infection and Immunity|May 1, 1978
Heat-stable enterotoxin from Escherichia coli: factors involved in growth and toxin productionW M Johnson, H Lior, K G Johnson
Lancet (London, England)|January 1, 1983
Cytotoxic Escherichia coli O157:H7 associated with haemorrhagic colitis in CanadaW M Johnson, H Lior, G S Bezanson
The International Journal of Biochemistry & Cell Biology|October 12, 2004
Mcl-1Jorg Michels, Peter W M Johnson, Graham Packham
Pageof 22